ZLD 6.36% 58.5¢ zelira therapeutics limited

Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-63

  1. 691 Posts.
    lightbulb Created with Sketch. 160
    Comnicon

    Investors are getting savvy and have access to lots of information. They are not easily tricked by science - they have good opportunities to get advice on how to interpret which trials are genuine and which ones are capital market storytelling.

    IMHO
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.